Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoantibody pattern in non-A, non-B hepatitis.

F Caredda, A d'Arminio Monforte, E Rossi

    Infection
    |March 1, 1984
    PubMed
    Summary

    Autoantibodies like smooth muscle and anti-reticulin antibodies are common in non-A, non-B hepatitis. Anti-nuclear antibodies may indicate progression to chronic liver disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Long-term trajectories of hepatic and metabolic biomarkers after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral therapy-experienced people with HIV with and without hepatic coinfection: Data from the ICONA cohort.

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2025
    Same author

    Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians' and nurses' points of view.

    The Journal of antimicrobial chemotherapy·2024
    Same author

    Clinical characteristics of women with HIV in the RESPOND cohort: A descriptive analysis and comparison to men.

    HIV medicine·2024
    Same author

    Monkeypox epidemic in prisons: How to prevent it?

    The Lancet regional health. Europe·2022
    Same author

    Awareness and perception of accuracy of the Undetectable=Untransmittable message (U=U) in Italy: results from a survey among PLWHA, infectious-diseases physicians and people having unprotected sex.

    AIDS care·2022
    Same author

    The impact of DAA-mediated HCV eradication on CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort.

    Journal of viral hepatitis·2021

    Area of Science:

    • Hepatology
    • Immunology
    • Virology

    Background:

    • Non-A, non-B hepatitis is a significant cause of liver disease.
    • Autoimmunity may play a role in the pathogenesis and progression of hepatitis.
    • Understanding autoantibody profiles can aid in predicting disease outcomes.

    Purpose of the Study:

    • To investigate the prevalence and significance of organ and non-organ specific autoantibodies in patients with non-A, non-B hepatitis.
    • To determine if autoantibody patterns correlate with epidemiological factors, disease severity, or clinical outcomes.
    • To assess the role of autoantibodies in the progression to chronic liver disease.

    Main Methods:

    • Indirect immunofluorescence was used to test acute and convalescent sera from 44 patients.
    • Sera were analyzed for smooth muscle antibodies, brush border antibodies, anti-reticulin antibodies, and anti-nuclear antibodies.
    • Autoantibody results were correlated with epidemiological data, liver function tests, and clinical outcomes (recovery vs. chronic disease).

    Main Results:

    • Smooth muscle antibodies were detected in 36.4% of acute sera, while brush border and anti-reticulin antibodies were found in 13.6%.
    • Anti-nuclear antibodies were present in only 4.5% of acute sera.
    • While autoantibody patterns generally did not correlate with initial disease factors, a significant increase in anti-nuclear antibodies was observed in patients progressing to chronic liver disease.

    Conclusions:

    • Autoimmunity, particularly the presence of smooth muscle antibodies, is frequently observed in acute non-A, non-B hepatitis.
    • The development of anti-nuclear antibodies during convalescence may be a marker for progression to chronic liver disease.
    • Further research is needed to clarify the clinical significance of these autoantibodies in long-term hepatitis sequelae.

    Related Experiment Videos